Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$122.0 - $145.31 $610 - $726
5 Added 6.25%
85 $11,000
Q2 2023

Jul 24, 2023

BUY
$122.5 - $147.16 $9,800 - $11,772
80 New
80 $9,000
Q1 2022

Apr 29, 2022

BUY
$129.64 - $160.7 $1,037 - $1,285
8 New
8 $1,000
Q1 2020

Apr 27, 2020

SELL
$87.74 - $152.74 $1,579 - $2,749
-18 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$121.81 - $142.95 $974 - $1,143
8 Added 80.0%
18 $3,000
Q2 2018

Jul 27, 2018

BUY
$146.33 - $183.18 $1,463 - $1,831
10 New
10 $2,000
Q2 2018

Jul 20, 2018

SELL
$146.33 - $183.18 $1,463 - $1,831
-10 Closed
0 $0
Q3 2017

Oct 23, 2017

BUY
$142.62 - $155.6 $1,426 - $1,556
10
10 $1,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.